Article info
PDFLetters to the editor
Complete response to erlotinib treatment in brain metastases from recurrent NSCLC
- Correspondence to:
Professor C Boshoff
Wolfson Institute for Biomedical Research, University College London, London WC1E 6BT, UK; c.boshoff{at}ucl.ac.uk
Citation
Complete response to erlotinib treatment in brain metastases from recurrent NSCLC
Publication history
- First published January 5, 2006.
Online issue publication
September 01, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 Thorax